Skip to main content
. 2021 Nov 9;37(1):87–94. doi: 10.1002/jbmr.4461

Table 2.

Incidence of Fracture and Mortality During the Follow‐Up

Parameter All incident low‐trauma fractures Incident MOF Mortality
Patients n (%) PY Incidence per 1000 PY (95% CI) IRR (95% CI) p Patients n (%) PY Incidence per 1000 PY (95% CI) IRR (95% CI) p Patients n (%) PY Incidence per 1000 PY (95% CI) IRR (95% CI) p
Total follow‐up
AFF (n = 55) 31 (56) 218 142 (100–202) 1.30 (0.82–2.04) 0.117 23 (42) 220 104 (69–157) 1.28 (0.74–2.15) 0.171 5 (9) 340 15 (6–35) 0.29 (0.09, 0.75) 0.002
pMOF (n = 165) 61 (37) 560 109 (85–140) 46 (28) 562 82 (61–109) 36 (22) 713 50 (36–70)
Imminent risk*
AFF (n = 55) 13 (24) 91 143 (83–246) 1.11 (0.54–2.15) 0.364 9 (16) 105 86 (45–165) 0.86 (0.36–1.86) 0.359 0 (0) 105 0 NA 0.038
pMOF (n = 165) 36 (22) 280 128 (93–178) 30 (18) 301 100 (70–143) 9 (5) 318 28 (15–54)

Bold values are significant at p < 0.05.. AFF = atypical femoral fracture; CI = confidence interval; IRR = incidence rate ratio; MOF = major osteoporotic fracture; pMOF = peripheral major osteoporotic fracture; PY = patient‐years. * follow‐up censored at maximum 2 years